← Back to Search

Neurostimulation Device

Micro-Implantable Pulse Generator for Chronic Pain (COMFORT Trial)

N/A
Recruiting
Research Sponsored by Nalu Medical, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subject has been diagnosed with one or more of the conditions listed below in the low back, shoulder, knee, or foot (including ankle):Post-surgical/post-traumatic peripheral neuralgia including but not limited to pain due to peripheral nerve injury, post-surgical scar formation, nerve entrapment; Mononeuropathy, specified or unspecified or in diseases classified elsewhere; Other neuralgia or neuropathic pain; Osteoarthritic pain.
Subject should have a pain score of at least 6, in the target area of pain, as recorded on the BPI-Q5 (NRS) at screening.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3, 6 and 12 months
Awards & highlights

COMFORT Trial Summary

This trial is testing whether adding peripheral nerve stimulation to conventional medical management is more effective and safe than just using conventional medical management for chronic, intractable peripheral neuralgia that is of post-traumatic or post-surgical origin.

Who is the study for?
Adults aged 18-80 with chronic, intractable peripheral neuropathic pain for at least 6 months, not including the face. Pain must be mainly neuropathic from conditions like nerve injury or osteoarthritis. Participants need a pain score of at least 6 and stable medication use for 30 days. They can't have other active implants, recent successful pain treatments, uncontrolled mental health issues, allergies to device materials, certain medical conditions or be pregnant.Check my eligibility
What is being tested?
The trial is testing the Nalu Neurostimulation System plus usual medical care against medical care alone for treating long-term peripheral neuralgia after trauma or surgery. It's a prospective study where participants are randomly assigned to either receive the new treatment or stick with standard care.See study design
What are the potential side effects?
Possible side effects may include discomfort at the implant site, skin irritation from adhesives used in the device components, and potential infection risks associated with any implanted device.

COMFORT Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have nerve or joint pain in my back, shoulder, knee, or foot due to surgery, injury, or arthritis.
Select...
My pain level in the target area is at least 6 out of 10.
Select...
I am between 18 and 80 years old.
Select...
My pain level in the target area is at least 6 out of 10.

COMFORT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3, 6 and 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3, 6 and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Effectiveness: Responder rates between groups
Safety: Rate of serious and non-serious adverse events between groups
Secondary outcome measures
Functional Outcomes: Change in ODI, BDI, EQ-5D, BPI from baseline
Responder Rates between groups at 12-months
Responder Rates between groups at 6-months
+1 more

COMFORT Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Conventional Medical ManagementExperimental Treatment1 Intervention
Control arm conventional medical management only
Group II: PNS Therapy plus Conventional Medical ManagementActive Control2 Interventions
peripheral nerve stimulator plus conventional medical management

Find a Location

Who is running the clinical trial?

Nalu Medical, Inc.Lead Sponsor
2 Previous Clinical Trials
210 Total Patients Enrolled
1 Trials studying Peripheral Neuropathy
100 Patients Enrolled for Peripheral Neuropathy
Patrick MartinStudy DirectorNalu Medical
2 Previous Clinical Trials
210 Total Patients Enrolled
1 Trials studying Peripheral Neuropathy
100 Patients Enrolled for Peripheral Neuropathy

Media Library

Nalu Neurostimulation System for PNS (Neurostimulation Device) Clinical Trial Eligibility Overview. Trial Name: NCT05287373 — N/A
Peripheral Neuropathy Research Study Groups: Conventional Medical Management, PNS Therapy plus Conventional Medical Management
Peripheral Neuropathy Clinical Trial 2023: Nalu Neurostimulation System for PNS Highlights & Side Effects. Trial Name: NCT05287373 — N/A
Nalu Neurostimulation System for PNS (Neurostimulation Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05287373 — N/A
Peripheral Neuropathy Patient Testimony for trial: Trial Name: NCT05287373 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the primary objective of this trial?

"According to the data provided by Nalu Medical, Inc., this trial's principal outcome will be evaluated over a 3-month timeframe. This primary indicator of success is titled "Effectiveness: Responder Rates between groups" and assesses the percentage of patients who have experienced pain relief exceeding 50% from their baseline as measured on the BPI-Q5(NRS). Additionally, secondary outcomes such as safety assessment (which looks into serious & non-serious events), functional outcomes (change in ODI, BDI, EQ-5D and BPI scores) and responder rates at 6 months are also being monitored."

Answered by AI

Is there an opportunity for me to participate in this experiment?

"This clinical trial is currently seeking 100 individuals, aged 18 to 80, who present with chronic pain. All patients must meet the specified criteria which include: having a diagnosis of post-surgical/post-traumatic peripheral neuralgia in one of four areas (low back, shoulder knee or foot), experiencing intractable neuropathic pain for at least six months and reporting a BPI score of 6 or higher; being psychologically equipped to receive PNS therapy through standard practice; displaying the capacity to correctly place an adhesive clip on their body where necessary; taking stable CMM medication for 30 days prior to enrolment and not escalating their dose within"

Answered by AI

Is this research initiative currently recruiting participants?

"According to clinicaltrials.gov, this research trial is actively searching for participants with the posting date of January 31st 2022 and last modified on March 10th 2022."

Answered by AI

Does this research endeavor accept enrollees who are younger than 75 years of age?

"To be considered for inclusion on this trial, applicants must meet the age criteria of 18 to 80. Additionally, there are 39 different trials available for those below 18 and 480 tailored towards seniors aged 65 or above."

Answered by AI

What is the current number of participants in this research endeavor?

"Affirmative. Clinicaltrials.gov indicates that this clinical trial, which was initially posted on the 31st of January 2022, is currently recruiting volunteers. 100 individuals need to be sourced from 5 distinct sites for participation in the study."

Answered by AI

How many sites have been chosen to conduct this research?

"Currently, 5 clinics are enrolling patients in this medical trial. Institutions such as the Institute of Precision Pain Medicine and International Spine, Pain and Performance Center have joined alongside Denver Back pain Specialists, with a few other locations joining them."

Answered by AI

Who else is applying?

What state do they live in?
Arizona
What site did they apply to?
Northwest Pain Care
Arizona Pain Specialists
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
1

Why did patients apply to this trial?

I am tired of chasing the pain. I have to workout hard and it’s immobilizing sometimes. I can handle pain but not like this.
PatientReceived 1 prior treatment

What questions have other patients asked about this trial?

How long, when and how much? Is the treatment free or do I pay?
PatientReceived 2+ prior treatments

How responsive is this trial?

Average response time
  • < 1 Day
Typically responds via
Email
Most responsive sites:
  1. Arizona Pain Specialists: < 24 hours
~47 spots leftby Apr 2025